DONOVAN JONES Insider Trading $CPAH COUNTERPATH CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DONOVAN JONES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DONOVAN JONES. DONOVAN JONES is President & CEO in COUNTERPATH CORP ($CPAH) and President & COO in COUNTERPATH CORP ($CPAH).
DONOVAN JONES in COUNTERPATH CORP
Trading Symbol: CPAHIndustry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DONOVAN JONES: President & CEO, President & COO
Holdings: 89,466 shares
Current Value: $231,717
Latest Transaction: Oct 11 2018
$CPAH Market Capitalization: $11.33M
$CPAH Previous Close: $2.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DONOVAN JONES in COUNTERPATH CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.61 | 116 | 303 | 89,582 | 89.5 K to 89.6 K (+0.13 %) |
Oct 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.64 | 229 | 604 | 89,466 | 89.2 K to 89.5 K (+0.26 %) |
Sep 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.82 | 214 | 602 | 89,237 | 89 K to 89.2 K (+0.24 %) |
Sep 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.85 | 423 | 1,206 | 89,023 | 88.6 K to 89 K (+0.48 %) |
Aug 10 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.98 | 203 | 605 | 88,600 | 88.4 K to 88.6 K (+0.23 %) |
Aug 10 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.83 | 426 | 1,207 | 88,397 | 88 K to 88.4 K (+0.48 %) |
Jul 30 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 45,661 | 0 | 206,587 | |
Jul 12 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.04 | 199 | 605 | 87,971 | 87.8 K to 88 K (+0.23 %) |
Jul 12 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.28 | 368 | 1,208 | 87,772 | 87.4 K to 87.8 K (+0.42 %) |
Jun 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.41 | 44 | 150 | 87,404 | 87.4 K to 87.4 K (+0.05 %) |
Jun 11 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.47 | 87 | 302 | 87,360 | 87.3 K to 87.4 K (+0.10 %) |
May 08 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.31 | 46 | 152 | 87,273 | 87.2 K to 87.3 K (+0.05 %) |
May 08 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.44 | 88 | 303 | 87,228 | 87.1 K to 87.2 K (+0.10 %) |
Apr 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.65 | 41 | 150 | 87,140 | 87.1 K to 87.1 K (+0.05 %) |
Apr 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.65 | 41 | 150 | 87,140 | 87.1 K to 87.1 K (+0.05 %) |
Apr 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.41 | 88 | 300 | 87,098 | 87 K to 87.1 K (+0.10 %) |
Apr 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.41 | 88 | 300 | 87,098 | 87 K to 87.1 K (+0.10 %) |
Mar 06 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 4.73 | 32 | 151 | 87,010 | 87 K to 87 K (+0.04 %) |
Mar 06 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 4.73 | 64 | 303 | 86,978 | 86.9 K to 87 K (+0.07 %) |
Feb 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 5.49 | 28 | 154 | 86,914 | 86.9 K to 86.9 K (+0.03 %) |
Feb 09 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 4.58 | 66 | 302 | 86,887 | 86.8 K to 86.9 K (+0.08 %) |
Feb 01 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 5.13 | 956 | 4,904 | 86,821 | 85.9 K to 86.8 K (+1.11 %) |
Feb 01 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 5.47 | 1,793 | 9,810 | 85,864 | 84.1 K to 85.9 K (+2.13 %) |
Jan 18 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 5.06 | 30 | 152 | 84,072 | 84 K to 84.1 K (+0.04 %) |
Jan 18 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 5.06 | 30 | 152 | 84,072 | 84 K to 84.1 K (+0.04 %) |
Jan 18 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 8.97 | 34 | 305 | 84,042 | 84 K to 84 K (+0.04 %) |
Jan 18 2018 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 8.97 | 34 | 305 | 84,042 | 84 K to 84 K (+0.04 %) |
Dec 18 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 2.89 | 100,000 | 289,000 | 180,000 | |
Dec 04 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.02 | 150 | 454 | 84,008 | 83.9 K to 84 K (+0.18 %) |
Nov 06 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.27 | 138 | 452 | 83,859 | 83.7 K to 83.9 K (+0.16 %) |
Oct 03 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 26,753 | 0 | 160,926 | |
Oct 03 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.35 | 135 | 452 | 83,720 | 83.6 K to 83.7 K (+0.16 %) |
Sep 05 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 26,753 | 0 | 160,926 | |
Sep 05 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.23 | 140 | 452 | 83,585 | 83.4 K to 83.6 K (+0.17 %) |
Aug 04 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 26,753 | 0 | 160,926 | |
Aug 04 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.19 | 142 | 453 | 83,445 | 83.3 K to 83.4 K (+0.17 %) |
Jul 24 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Buy | P | 2.20 | 11,368 | 25,010 | 83,303 | 71.9 K to 83.3 K (+15.80 %) |
Jul 18 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 26,753 | 0 | 160,926 | |
Jul 07 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.58 | 614 | 1,585 | 71,935 | 71.3 K to 71.9 K (+0.86 %) |
Jun 05 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.95 | 921 | 2,718 | 71,321 | 70.4 K to 71.3 K (+1.31 %) |
May 05 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.04 | 893 | 2,715 | 70,401 | 69.5 K to 70.4 K (+1.28 %) |
Apr 06 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.15 | 862 | 2,715 | 69,507 | 68.6 K to 69.5 K (+1.26 %) |
Mar 09 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.30 | 823 | 2,716 | 68,645 | 67.8 K to 68.6 K (+1.21 %) |
Feb 09 2017 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.30 | 823 | 2,717 | 67,822 | 67 K to 67.8 K (+1.23 %) |
Dec 19 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Buy | P | 2.05 | 12,195 | 25,000 | 66,147 | 54 K to 66.1 K (+22.60 %) |
Dec 08 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.90 | 937 | 2,717 | 53,952 | 53 K to 54 K (+1.77 %) |
Oct 31 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.69 | 1,011 | 2,717 | 53,015 | 52 K to 53 K (+1.94 %) |
Oct 05 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.68 | 1,013 | 2,716 | 52,004 | 51 K to 52 K (+1.99 %) |
Sep 06 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.85 | 953 | 2,717 | 50,991 | 50 K to 51 K (+1.90 %) |
Aug 08 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 2.40 | 40,000 | 96,000 | 105,000 | |
Aug 08 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.00 | 906 | 2,718 | 50,038 | 49.1 K to 50 K (+1.84 %) |
Jul 18 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 16,152 | 0 | 134,174 | |
Jul 18 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 2.40 | 40,000 | 96,000 | 105,000 | |
Jul 07 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.25 | 836 | 2,718 | 49,133 | 48.3 K to 49.1 K (+1.73 %) |
Jun 08 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.00 | 906 | 2,718 | 48,297 | 47.4 K to 48.3 K (+1.91 %) |
May 24 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 2.50 | 1,087 | 2,718 | 47,391 | 46.3 K to 47.4 K (+2.35 %) |
Mar 17 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Buy | P | 2.08 | 1,500 | 3,120 | 45,442 | 43.9 K to 45.4 K (+3.41 %) |
Mar 09 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.05 | 891 | 2,717 | 43,942 | 43.1 K to 43.9 K (+2.07 %) |
Feb 10 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.19 | 852 | 2,718 | 43,051 | 42.2 K to 43.1 K (+2.02 %) |
Apr 11 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.15 | 862 | 2,715 | 46,305 | 45.4 K to 46.3 K (+1.90 %) |
Jan 11 2016 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.98 | 682 | 2,717 | 42,200 | 41.5 K to 42.2 K (+1.64 %) |
Dec 14 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 3.91 | 695 | 2,718 | 41,518 | 40.8 K to 41.5 K (+1.70 %) |
Nov 05 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 4.10 | 662 | 2,717 | 40,823 | 40.2 K to 40.8 K (+1.65 %) |
Oct 29 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Buy | P | 0.32 | 1,000 | 320 | 401,614 | 400.6 K to 401.6 K (+0.25 %) |
Oct 13 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.55 | 4,962 | 2,717 | 398,614 | 393.7 K to 398.6 K (+1.26 %) |
Sep 02 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.59 | 4,624 | 2,717 | 393,653 | 389 K to 393.7 K (+1.19 %) |
Aug 19 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Option Exercise | A | 0.00 | 159,408 | 0 | 1,180,214 | |
Aug 10 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.58 | 4,715 | 2,717 | 389,029 | 384.3 K to 389 K (+1.23 %) |
Jul 06 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.64 | 4,228 | 2,716 | 384,314 | 380.1 K to 384.3 K (+1.11 %) |
Jun 02 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.87 | 3,119 | 2,717 | 380,086 | 377 K to 380.1 K (+0.83 %) |
May 04 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.61 | 4,489 | 2,717 | 376,967 | 372.5 K to 377 K (+1.21 %) |
Apr 07 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.65 | 4,210 | 2,717 | 372,479 | 368.3 K to 372.5 K (+1.14 %) |
Mar 05 2015 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & CEO | Grant | A | 0.59 | 4,604 | 2,716 | 368,269 | 363.7 K to 368.3 K (+1.27 %) |
Aug 15 2006 | CPAH | COUNTERPATH CORP | JONES DONOVAN | President & COO | Option Exercise | A | 0.61 | 678,000 | 413,580 | 1,695,000 |
Page: 1